Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Research Article

Energy Metabolism Dysregulation in Myocardial Infarction: An Integrative Analysis of Ischemic Cardiomyopathy

In Press, (this is not the final "Version of Record"). Available online 26 July, 2024
Author(s): Zongtao Wang, Zhixin Xie, Tudi Li, Rong Chen, Zhihuan Zeng and Jun Guo*
Published on: 26 July, 2024

DOI: 10.2174/0115701611289159240724114844

Price: $95

Abstract

Background: Myocardial metabolism is closely related to functional changes after myocardial infarction (MI).

Objective: This study aimed to present an integrative examination of human ischemic cardiomyopathy.

Methods: We used both GSE121893 single-cell suspension sequencing and GSE19303 transcription microarray data sets from the GEO database, along with a murine MI model for full-spectrum metabolite detection. Through a systematic investigation that involved differential metabolite identification and functional enrichment analysis, we shed light on the pivotal role of energy metabolism dysregulation in the progression of MI.

Results: Our findings revealed an association between the core regulatory genes CDKN1A, FOS, ITGB4, and MAP2K1 and the underlying pathophysiology of the disease. These genes are identified as critical elements in the complex landscape of myocardial ischemic disorder, highlighting novel insights into therapeutic targets and the intricate biological mechanisms involved.

Conclusion: This analysis provides a framework for future research on the metabolic alterations associated with MI.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy